No. |
薬物名(臨床試験情報から抽出) |
DrugBank |
KEGG DRUG * |
KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 |
(+)- epicatechin |
Epicatechin |
- |
- |
- |
1件: 113 |
2 |
(-)-epicatechin |
Epicatechin |
- |
- |
- |
2件: 86, 113 |
3 |
12 mg/kg gsk2402968 |
- |
- |
- |
- |
1件: 113 |
4 |
2011-2012 seasonal flu vaccine |
- |
- |
- |
- |
2件: 3, 113 |
5 |
29180.00.00, 34681.00.00, 34681.01.00, 34681.02.00 |
- |
- |
- |
- |
1件: 113 |
6 |
3 mg/kg gsk2402968 |
- |
- |
- |
- |
1件: 113 |
7 |
4-benzyl-2-naphthalen-1-yl-1,2,4- thiadiazolidine-3,5-dione |
- |
- |
- |
- |
1件: 113 |
8 |
4-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione |
- |
- |
- |
- |
1件: 113 |
9 |
5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole |
- |
- |
- |
- |
1件: 113 |
10 |
6 mg/kg gsk2402968 |
- |
- |
- |
- |
1件: 113 |
11 |
750 mg metformin and 7.5 g l-citrulline daily p.o. |
Metformin |
D00944, D04966 |
2件: PRKAA1, PRKAA2 |
19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
1件: 113 |
12 |
9 mg/kg gsk2402968 |
- |
- |
- |
- |
1件: 113 |
13 |
Aav1-gamma-sarcoglycan vector injection |
- |
- |
- |
- |
1件: 113 |
14 |
Ace-031 (extension of cohort 1 from core study, a031-03) |
- |
- |
- |
- |
1件: 113 |
15 |
Ace-031 (extension of cohort 2 from core study, a031-03) |
- |
- |
- |
- |
1件: 113 |
16 |
Ace-031 (extension of cohort 3 from core study, a031-03) |
- |
- |
- |
- |
1件: 113 |
17 |
Ace-031 0.5 mg/kg q4wk |
- |
- |
- |
- |
1件: 113 |
18 |
Ace-031 1.0 mg/kg q2wk |
- |
- |
- |
- |
1件: 113 |
19 |
Ace-083 |
- |
- |
- |
- |
2件: 10, 113 |
20 |
Acetate |
Acetate |
- |
- |
- |
40件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 70, 71, 73, 75, 76, 78, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 235, 265, 288, 298, 299 |
21 |
Actonel once a week 5mg film coated tablets |
Risedronic acid |
D00942, D03234, D08484 |
1件: FDPS |
4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
1件: 113 |
22 |
Albuterol |
Salbutamol |
D02147 |
1件: ADRB2 |
8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
8件: 12, 13, 86, 89, 113, 231, 256, 299 |
23 |
Allogeneic cardiosphere-derived cells (cap-1002) |
- |
- |
- |
- |
1件: 113 |
24 |
Anti-myostatin adnectin |
- |
- |
- |
- |
1件: 113 |
25 |
Arginine |
L-arginine |
D02982 |
- |
- |
5件: 67, 78, 113, 251, 299 |
26 |
Aspirin |
Acetylsalicylic acid |
D00109 |
2件: PTGS1, PTGS2 |
21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
27 |
Ataluren |
Ataluren |
D09323 |
- |
- |
6件: 19, 113, 140, 246, 299, 329 |
28 |
Ataluren (ptc124) |
Ataluren |
D09323 |
- |
- |
2件: 113, 299 |
29 |
Ataluren 1000 mg |
Ataluren |
D09323 |
- |
- |
1件: 113 |
30 |
Ataluren 125 mg |
Ataluren |
D09323 |
- |
- |
1件: 113 |
31 |
Ataluren 250 mg |
Ataluren |
D09323 |
- |
- |
1件: 113 |
32 |
Atyr1940 |
- |
- |
- |
- |
1件: 113 |
33 |
Autologous bone marrow mononuclear cell transplantation |
- |
- |
- |
- |
1件: 113 |
34 |
Avi-4658 |
- |
- |
- |
- |
1件: 113 |
35 |
Avi-4658 (eteplirsen) |
Eteplirsen |
D09900 |
1件: DMD |
4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis |
1件: 113 |
36 |
Avi-4658 (pmo) |
- |
- |
- |
- |
1件: 113 |
37 |
Avi-4658 for injection |
- |
- |
- |
- |
1件: 113 |
38 |
Balance |
Isoxaflutole |
- |
- |
- |
8件: 5, 6, 13, 18, 81, 113, 149, 299 |
39 |
Bisoprolol |
Bisoprolol |
D00634, D02342 |
1件: ADRB1 |
10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
3件: 67, 86, 113 |
40 |
Bisoprolol fumarate |
Bisoprolol |
D00634, D02342 |
1件: ADRB1 |
10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
1件: 113 |
41 |
Bisphosphonate treatment |
- |
- |
- |
- |
2件: 113, 299 |
42 |
Blood test |
- |
- |
- |
- |
5件: 36, 86, 113, 162, 299 |
43 |
Bls-m22 |
- |
- |
- |
- |
1件: 113 |
44 |
Bmn 044 |
- |
- |
- |
- |
1件: 113 |
45 |
Bmn 044 iv 6 mg/kg |
- |
- |
- |
- |
1件: 113 |
46 |
Bmn 044 iv 9 mg/kg |
- |
- |
- |
- |
1件: 113 |
47 |
Bmn 044 sc 6 mg/kg |
- |
- |
- |
- |
1件: 113 |
48 |
Bmn 053 |
- |
- |
- |
- |
1件: 113 |
49 |
Bms-986089-01, anti-myostatin |
- |
- |
- |
- |
1件: 113 |
50 |
Botulinum toxin type a |
Botulinum toxin type a |
D00783 |
1件: SNAP25 |
2件: Insulin secretion, Synaptic vesicle cycle |
10件: 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 |
51 |
Cabaletta |
Trehalose |
- |
- |
- |
1件: 113 |
52 |
Calcichew d3 forte |
- |
- |
- |
- |
1件: 113 |
53 |
Calcifediol |
Calcifediol |
D00122 |
1件: VDR |
4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
1件: 113 |
54 |
Canakinumab |
Canakinumab |
D09315 |
1件: IL1B |
40件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease (IBD), Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Prion diseases, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
55 |
Canakinumab injection [ilaris] |
Canakinumab |
D09315 |
1件: IL1B |
40件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease (IBD), Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Prion diseases, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
1件: 113 |
56 |
Cap-1002 |
- |
- |
- |
- |
1件: 113 |
57 |
Capsaicin |
Capsaicin |
D00250 |
1件: TRPV1 |
2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
6件: 2, 6, 19, 86, 113, 226 |
58 |
Cardiovascular profile |
- |
- |
- |
- |
1件: 113 |
59 |
Carvedilol |
Carvedilol |
D00255, D03415 |
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
4件: 6, 57, 86, 113 |
60 |
Casimersen |
Casimersen |
- |
- |
- |
1件: 113 |
61 |
Cat-1004 |
- |
- |
- |
- |
1件: 113 |
62 |
Cialis 10 mg film-coated tablets |
Tadalafil |
D02008 |
1件: PDE5A |
3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
2件: 86, 113 |
63 |
Cialis 2.5 mg film-coated tablets |
Tadalafil |
D02008 |
1件: PDE5A |
3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
2件: 86, 113 |
64 |
Cialis 20 mg film-coated tablets |
Tadalafil |
D02008 |
1件: PDE5A |
3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
2件: 86, 113 |
65 |
Cialis 5 mg film-coated tablets |
Tadalafil |
D02008 |
1件: PDE5A |
3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
2件: 86, 113 |
66 |
Citrulline |
L-citrulline |
D07706 |
- |
- |
2件: 86, 113 |
67 |
Coenzyme q10 |
Ubidecarenone |
D01065 |
- |
- |
10件: 2, 6, 8, 10, 46, 57, 113, 193, 214, 215 |
68 |
Coenzyme q10 and lisinopril |
Lisinopril |
D00362, D08131 |
1件: ACE |
4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system |
1件: 113 |
69 |
Cosyntropin |
Tetracosactide |
D00284 |
1件: MC2R |
5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
3件: 83, 113, 145 |
70 |
Cosyntropin acetate |
Acetate |
- |
- |
- |
1件: 113 |
71 |
Cr13c |
- |
- |
- |
- |
1件: 113 |
72 |
Crd007 |
- |
- |
- |
- |
1件: 113 |
73 |
Creatine |
Creatine |
- |
- |
- |
12件: 1, 2, 5, 6, 8, 13, 46, 49, 50, 113, 156, 201 |
74 |
Creatine monohydrate |
Creatine |
- |
- |
- |
4件: 2, 8, 113, 156 |
75 |
Creatine-13c |
Creatine |
- |
- |
- |
1件: 113 |
76 |
Cyclosporin |
Ciclosporin |
D00184 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
16件: 14, 38, 39, 49, 53, 56, 60, 62, 63, 97, 113, 164, 222, 223, 274, 326 |
77 |
Cyclosporin a |
Ciclosporin |
D00184 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
11件: 14, 38, 39, 49, 53, 56, 60, 62, 63, 113, 164 |
78 |
Date |
Date |
- |
- |
- |
3件: 6, 88, 113 |
79 |
Decortin |
Prednisone |
D00473 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
5件: 46, 96, 97, 113, 145 |
80 |
Deflazacort |
Deflazacort |
D03671 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
2件: 30, 113 |
81 |
Dehydroepiandrosterone |
Prasterone |
D08409 |
3件: AR, ESR1, ESR2 |
11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
5件: 49, 53, 83, 96, 113 |
82 |
Dehydroepiandrosterone 100 and 400 mg |
Prasterone |
D08409 |
3件: AR, ESR1, ESR2 |
11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
1件: 113 |
83 |
Dexmedetomidine |
Dexmedetomidine |
D00514, D01205 |
3件: ADRA2A, ADRA2B, ADRA2C |
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
11件: 2, 4, 6, 21, 34, 70, 113, 212, 215, 226, 280 |
84 |
Dilatrend |
Carvedilol |
D00255, D03415 |
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
1件: 113 |
85 |
Dosing extension |
- |
- |
- |
- |
1件: 113 |
86 |
Drisapersen |
Drisapersen |
D10114 |
1件: DMD |
4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis |
1件: 113 |
87 |
Drisapersen sodium |
Drisapersen |
D10114 |
1件: DMD |
4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis |
1件: 113 |
88 |
Ds-5141b |
- |
- |
- |
- |
1件: 113 |
89 |
Edasalonexent |
Edasalonexent |
- |
- |
- |
1件: 113 |
90 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
8件: 6, 13, 17, 28, 85, 113, 206, 299 |
91 |
Emd 87580 |
- |
- |
- |
- |
1件: 113 |
92 |
Enahexal®, 10mg |
- |
- |
- |
- |
1件: 113 |
93 |
Enalapril |
Enalapril |
D00621, D07892 |
1件: ACE |
4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system |
4件: 19, 46, 66, 113 |
94 |
Enalhexal®, 5 mg |
- |
- |
- |
- |
1件: 113 |
95 |
Epa and dha |
- |
- |
- |
- |
1件: 113 |
96 |
Epicatechin |
Epicatechin |
- |
- |
- |
2件: 86, 113 |
97 |
Epigallocatechin |
Epigallocatechin |
- |
- |
- |
4件: 13, 28, 85, 113 |
98 |
Epigallocatechin-gallate |
Epigallocatechin |
- |
- |
- |
1件: 113 |
99 |
Eplerenone |
Eplerenone |
D01115 |
1件: NR3C2 |
1件: Aldosterone-regulated sodium reabsorption |
3件: 75, 113, 215 |
100 |
Erx-963 |
- |
- |
- |
- |
1件: 113 |
101 |
Eteplirsen |
Eteplirsen |
D09900 |
1件: DMD |
4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis |
1件: 113 |
102 |
Eucardic |
Carvedilol |
D00255, D03415 |
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
1件: 113 |
103 |
Ev substance code: sub188638 |
- |
- |
- |
- |
1件: 113 |
104 |
Exondys 51 |
Eteplirsen |
D09900 |
1件: DMD |
4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis |
1件: 113 |
105 |
Ezutromid |
Ezutromid |
- |
- |
- |
1件: 113 |
106 |
Filgrastim |
Filgrastim |
D03235 |
1件: CSF3R |
5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
25件: 2, 6, 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 283, 284, 285, 331 |
107 |
Flavocoxid |
- |
- |
- |
- |
1件: 113 |
108 |
Gentamicin |
Gentamicin |
D01063, D08013 |
- |
- |
3件: 36, 113, 299 |
109 |
Gentamicin infusions twice a week for six months |
Gentamicin |
D01063, D08013 |
- |
- |
1件: 113 |
110 |
Givinostat |
Givinostat |
- |
- |
- |
1件: 113 |
111 |
Givinostat (hydrochloride monohydrate) |
Givinostat |
- |
- |
- |
1件: 113 |
112 |
Givinostat (idrocloruro monoidrato) |
Givinostat |
- |
- |
- |
1件: 113 |
113 |
Glutamine |
L-glutamine |
D00015 |
- |
- |
6件: 87, 96, 97, 113, 245, 299 |
114 |
Golodirsen |
- |
- |
- |
- |
1件: 113 |
115 |
Granulocyte colony-stimulating factor (filgrastim) |
Filgrastim |
D03235 |
1件: CSF3R |
5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
1件: 113 |
116 |
Gsk2402968 |
- |
- |
- |
- |
1件: 113 |
117 |
Gsk2402968 3mg/kg/week |
- |
- |
- |
- |
1件: 113 |
118 |
Gsk2402968 6 mg/kg/week |
- |
- |
- |
- |
1件: 113 |
119 |
Guanidine |
Guanidine |
D02437 |
- |
- |
1件: 113 |
120 |
H44aon188 |
- |
- |
- |
- |
1件: 113 |
121 |
Haemostasis tests |
- |
- |
- |
- |
1件: 113 |
122 |
Hidroferol |
- |
- |
- |
- |
1件: 113 |
123 |
Hidroferol® |
- |
- |
- |
- |
1件: 113 |
124 |
Hla-identical allogeneic mesoangioblasts |
- |
- |
- |
- |
1件: 113 |
125 |
Hmabs |
- |
- |
- |
- |
1件: 113 |
126 |
Hormonal profile |
- |
- |
- |
- |
1件: 113 |
127 |
Ht-100 |
- |
- |
- |
- |
1件: 113 |
128 |
Human umbilical cord mesenchymal stem cells |
- |
- |
- |
- |
2件: 13, 113 |
129 |
Ibuprofen |
Ibuprofen |
D00126, D01122, D04490, D06606 |
2件: PTGS1, PTGS2 |
21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
6件: 13, 46, 65, 113, 271, 299 |
130 |
Ibuprofen 200mg |
Ibuprofen |
D00126, D01122, D04490, D06606 |
2件: PTGS1, PTGS2 |
21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
1件: 113 |
131 |
Idebenone |
Idebenone |
D01750 |
- |
- |
4件: 6, 13, 113, 302 |
132 |
Idebenone 150 mg film-coated tablets |
Idebenone |
D01750 |
- |
- |
1件: 113 |
133 |
Ifetroban |
Ifetroban |
D04500 |
1件: TBXA2R |
3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
3件: 51, 86, 113 |
134 |
Igf-1 |
- |
- |
- |
- |
1件: 113 |
135 |
Inflammatory profile |
- |
- |
- |
- |
1件: 113 |
136 |
Ionis-dmpkrx |
- |
- |
- |
- |
1件: 113 |
137 |
Isosorbide |
Isosorbide |
D00347 |
- |
- |
1件: 113 |
138 |
Isosorbide dinitrate |
Isosorbide dinitrate |
D00516 |
- |
- |
1件: 113 |
139 |
Isosorbide dinitrate 20 mg |
Isosorbide dinitrate |
D00516 |
- |
- |
1件: 113 |
140 |
Isosorbide dinitrate 40 mg |
Isosorbide dinitrate |
D00516 |
- |
- |
1件: 113 |
141 |
Isosorbide dinitrate 60 mg |
Isosorbide dinitrate |
D00516 |
- |
- |
1件: 113 |
142 |
Isosorbide dinitrate 80 mg |
Isosorbide dinitrate |
D00516 |
- |
- |
1件: 113 |
143 |
Itf2357 |
- |
- |
- |
- |
3件: 96, 107, 113 |
144 |
Ketamine |
Ketamine |
D00711, D08098 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway |
5件: 13, 70, 113, 156, 215 |
145 |
L-arginine |
L-arginine |
D02982 |
- |
- |
4件: 67, 78, 113, 299 |
146 |
L-citrulline |
L-citrulline |
D07706 |
- |
- |
2件: 86, 113 |
147 |
L-citrulline and metformin & l-citrulline |
Metformin |
D00944, D04966 |
2件: PRKAA1, PRKAA2 |
19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
1件: 113 |
148 |
L-glutamine |
L-glutamine |
D00015 |
- |
- |
1件: 113 |
149 |
Lisinopril |
Lisinopril |
D00362, D08131 |
1件: ACE |
4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system |
5件: 46, 66, 67, 113, 222 |
150 |
Lonafarnib |
Lonafarnib |
D04768 |
2件: FNTA, FNTB |
1件: Terpenoid backbone biosynthesis |
2件: 113, 333 |
151 |
Losartan |
Losartan |
D00357, D08146 |
1件: AGTR1 |
14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
152 |
Losmapimod |
Losmapimod |
D09639 |
4件: MAPK11, MAPK12, MAPK13, MAPK14 |
53件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis (ALS), C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease (American trypanosomiasis), Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pertussis, Platelet activation, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection |
2件: 113, 222 |
153 |
Metabolic profile |
- |
- |
- |
- |
1件: 113 |
154 |
Metformin |
Metformin |
D00944, D04966 |
2件: PRKAA1, PRKAA2 |
19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
16件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285 |
155 |
Metformin 500mg |
Metformin |
D00944, D04966 |
2件: PRKAA1, PRKAA2 |
19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
1件: 113 |
156 |
Metformin and metformin & l-citrulline |
Metformin |
D00944, D04966 |
2件: PRKAA1, PRKAA2 |
19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
1件: 113 |
157 |
Methylphenidate |
Methylphenidate |
D01296, D04999 |
2件: SLC6A2, SLC6A3 |
6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle |
7件: 6, 13, 34, 84, 113, 179, 206 |
158 |
Metohexal® succ ® 23,75 mg retardtabletten |
- |
- |
- |
- |
1件: 113 |
159 |
Metohexal® succ ® 47,5 mg retardtabletten |
- |
- |
- |
- |
1件: 113 |
160 |
Metohexal® succ ® 95 mg retardtabletten |
- |
- |
- |
- |
1件: 113 |
161 |
Metoprolol |
Metoprolol |
D00601, D02358, D05011 |
1件: ADRB1 |
10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
6件: 17, 57, 58, 113, 193, 226 |
162 |
Metoprolol succinate |
Metoprolol |
D00601, D02358, D05011 |
1件: ADRB1 |
10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
4件: 57, 58, 113, 193 |
163 |
Mexiletine |
Mexiletine |
D00639, D08215 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A |
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
5件: 1, 2, 10, 113, 114 |
164 |
Mnk-1411 |
- |
- |
- |
- |
1件: 113 |
165 |
Monocytes and megacaryocytes culture and rna extraction |
- |
- |
- |
- |
1件: 113 |
166 |
Myo-029 |
- |
- |
- |
- |
1件: 113 |
167 |
Myoblast autologous graft |
- |
- |
- |
- |
1件: 113 |
168 |
Myoblast transplantation |
- |
- |
- |
- |
1件: 113 |
169 |
Myoblastes autologues |
- |
- |
- |
- |
1件: 113 |
170 |
N(4,5bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate |
Guanidine |
D02437 |
- |
- |
1件: 113 |
171 |
Nanosuspension) |
- |
- |
- |
- |
1件: 113 |
172 |
Nebivolol |
Nebivolol |
D05127 |
1件: ADRB1 |
10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
3件: 17, 113, 167 |
173 |
Needle biopsy of the vastus lateralis muscle |
- |
- |
- |
- |
1件: 113 |
174 |
Nitrate |
Nitrate |
D02313 |
- |
- |
3件: 58, 113, 299 |
175 |
Npc-14 |
- |
- |
- |
- |
1件: 113 |
176 |
Ns-065/ncnp-01 |
Viltolarsen |
D11528 |
1件: DMD |
4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis |
1件: 113 |
177 |
Ns-089/ncnp-02 |
- |
- |
- |
- |
1件: 113 |
178 |
Nébivolol |
- |
- |
- |
- |
1件: 113 |
179 |
Omigapil |
Omigapil |
- |
- |
- |
1件: 113 |
180 |
Oxatomide |
Oxatomide |
D01773 |
1件: ALOX5 |
6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis |
1件: 113 |
181 |
Oxatomide (tinset) |
Oxatomide |
D01773 |
1件: ALOX5 |
6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis |
1件: 113 |
182 |
P-188 nf |
- |
- |
- |
- |
1件: 113 |
183 |
Pamrevlumab |
Pamrevlumab |
D10969 |
1件: CCN2 |
2件: Apelin signaling pathway, Hippo signaling pathway |
2件: 85, 113 |
184 |
Pamrevlumab (fg-3019) |
Pamrevlumab |
D10969 |
1件: CCN2 |
2件: Apelin signaling pathway, Hippo signaling pathway |
1件: 113 |
185 |
Pb1046 injection |
- |
- |
- |
- |
2件: 86, 113 |
186 |
Pemirolast |
Pemirolast |
D01088, D07476 |
- |
- |
1件: 113 |
187 |
Pending |
- |
- |
- |
- |
3件: 13, 113, 302 |
188 |
Pentoxifylline |
Pentoxifylline |
D00501 |
- |
- |
10件: 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 |
189 |
Pf-06252616 |
Domagrozumab |
D11047 |
1件: MSTN |
1件: Cytokine-cytokine receptor interaction |
1件: 113 |
190 |
Phosphorodiamidate morpholino oligomer |
- |
- |
- |
- |
1件: 113 |
191 |
Phosphorodiamidate morpholino oligomer for exon 53 skipping |
- |
- |
- |
- |
1件: 113 |
192 |
Powder for oral suspension) |
- |
- |
- |
- |
1件: 113 |
193 |
Prednisolone |
Prednisolone |
D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
38件: 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
194 |
Prednison |
- |
- |
- |
- |
2件: 46, 113 |
195 |
Prednisone |
Prednisone |
D00473 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
43件: 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
196 |
Pro044 |
- |
- |
- |
- |
1件: 113 |
197 |
Pro044 iv 6 mg/kg |
- |
- |
- |
- |
1件: 113 |
198 |
Pro044 iv 9 mg/kg |
- |
- |
- |
- |
1件: 113 |
199 |
Pro044 sc 6 mg/kg |
- |
- |
- |
- |
1件: 113 |
200 |
Pro045 |
- |
- |
- |
- |
1件: 113 |
201 |
Pro045, 0.15 mg/kg/week |
- |
- |
- |
- |
1件: 113 |
202 |
Pro045, 1.0 mg/kg/week |
- |
- |
- |
- |
1件: 113 |
203 |
Pro045, 3.0 mg/kg/week |
- |
- |
- |
- |
1件: 113 |
204 |
Pro045, 6.0 mg/kg/week |
- |
- |
- |
- |
1件: 113 |
205 |
Pro045, 9.0 mg/kg/week |
- |
- |
- |
- |
1件: 113 |
206 |
Pro045, selected dose |
- |
- |
- |
- |
1件: 113 |
207 |
Pro051 |
- |
- |
- |
- |
1件: 113 |
208 |
Protein-carbohydrate supplementation |
- |
- |
- |
- |
1件: 113 |
209 |
Ps188 |
- |
- |
- |
- |
1件: 113 |
210 |
Ps188 (company code) |
- |
- |
- |
- |
1件: 113 |
211 |
Ps220 |
- |
- |
- |
- |
1件: 113 |
212 |
Ps524 |
- |
- |
- |
- |
1件: 113 |
213 |
Ptc0161480, ptc124 compound 1a, rps2505, ptc-c124, 291844 |
- |
- |
- |
- |
1件: 113 |
214 |
Ptc124 |
- |
- |
- |
- |
4件: 19, 113, 246, 299 |
215 |
Ptc124 high dose |
- |
- |
- |
- |
1件: 113 |
216 |
Ptc124 low dose |
- |
- |
- |
- |
1件: 113 |
217 |
Raav1.cmv.hufollistatin344 |
- |
- |
- |
- |
2件: 15, 113 |
218 |
Raav1.cmv.hufollistin344 |
- |
- |
- |
- |
1件: 113 |
219 |
Raav2.5-cmv-minidystrophin (d3990) |
- |
- |
- |
- |
1件: 113 |
220 |
Raavrh74.mck.galgt2 |
- |
- |
- |
- |
1件: 113 |
221 |
Raavrh74.mck.micro-dystrophin |
- |
- |
- |
- |
1件: 113 |
222 |
Raavrh74.mhck7.micro-dystrophin |
- |
- |
- |
- |
1件: 113 |
223 |
Ramipril |
Ramipril |
D00421 |
1件: ACE |
4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system |
7件: 46, 49, 66, 67, 113, 218, 257 |
224 |
Ranolazine |
Ranolazine |
D05700, D05701 |
- |
- |
6件: 2, 58, 86, 113, 114, 130 |
225 |
Raxone |
Idebenone |
D01750 |
- |
- |
1件: 113 |
226 |
Recombinant human anti-gdf-8 antibody |
- |
- |
- |
- |
1件: 113 |
227 |
Regimen selection phase group 1 (completed) |
- |
- |
- |
- |
1件: 113 |
228 |
Regimen selection phase group 2 |
- |
- |
- |
- |
1件: 113 |
229 |
Regimen selection phase group 3 |
- |
- |
- |
- |
1件: 113 |
230 |
Resveratrol |
Resveratrol |
- |
- |
- |
3件: 8, 89, 113 |
231 |
Rhigf-i/rhigfbp-3 |
Mecasermin rinfabate |
D04870 |
2件: GHR, IGF1R |
33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
1件: 113 |
232 |
Rhigfbp-3 |
- |
- |
- |
- |
2件: 113, 195 |
233 |
Rimeporide |
Rimeporide |
- |
- |
- |
1件: 113 |
234 |
Risedronate |
Risedronic acid |
D00942, D03234, D08484 |
1件: FDPS |
4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
5件: 46, 66, 96, 113, 274 |
235 |
Risedronate sodium |
Risedronic acid |
D00942, D03234, D08484 |
1件: FDPS |
4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
2件: 113, 274 |
236 |
Ro7239361 |
- |
- |
- |
- |
1件: 113 |
237 |
Ro7239361 injections, 15 mg/syringe (21.4 mg/ml) |
- |
- |
- |
- |
1件: 113 |
238 |
Ro7239361 injections, 35 mg/syringe (50 mg/ml) |
- |
- |
- |
- |
1件: 113 |
239 |
Ro7239361 injections, 7.5 mg/syringe (10.7 mg/ml) |
- |
- |
- |
- |
1件: 113 |
240 |
Sandimmun |
Ciclosporin |
D00184 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
4件: 53, 60, 113, 226 |
241 |
Sandimmun optoral |
Ciclosporin |
D00184 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
2件: 53, 113 |
242 |
Scaavrh74.tmck.hsgca |
- |
- |
- |
- |
1件: 113 |
243 |
Sildenafil |
Sildenafil |
D02229, D08514 |
1件: PDE5A |
3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
15件: 6, 46, 50, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
244 |
Sleep parameters |
- |
- |
- |
- |
1件: 113 |
245 |
Smt c1100 |
- |
- |
- |
- |
1件: 113 |
246 |
Smt c1100 (f5 |
- |
- |
- |
- |
1件: 113 |
247 |
Smt c1100 (f5) |
- |
- |
- |
- |
1件: 113 |
248 |
Smt c1100 (f6 |
- |
- |
- |
- |
1件: 113 |
249 |
Smt c1100 (f6) |
- |
- |
- |
- |
1件: 113 |
250 |
Snt-mc17 |
- |
- |
- |
- |
1件: 113 |
251 |
Sodium nitrate |
Nitrate |
D02313 |
- |
- |
2件: 58, 113 |
252 |
Sodium nitrate - double dose |
Nitrate |
D02313 |
- |
- |
1件: 113 |
253 |
Somatokine/iplex |
- |
- |
- |
- |
1件: 113 |
254 |
Somatropin |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
15件: 2, 3, 19, 46, 74, 75, 78, 96, 113, 193, 195, 265, 274, 276, 299 |
255 |
Spironolactone |
Spironolactone |
D00443 |
1件: NR3C2 |
1件: Aldosterone-regulated sodium reabsorption |
6件: 58, 67, 86, 113, 218, 225 |
256 |
Srp-4045 |
- |
- |
- |
- |
1件: 113 |
257 |
Srp-4053 |
- |
- |
- |
- |
1件: 113 |
258 |
Srp-5051 |
- |
- |
- |
- |
1件: 113 |
259 |
Srp-9001 |
- |
- |
- |
- |
1件: 113 |
260 |
Srp-9003 |
- |
- |
- |
- |
1件: 113 |
261 |
Stem cell |
- |
- |
- |
- |
2件: 2, 113 |
262 |
Stem cells |
- |
- |
- |
- |
4件: 2, 4, 96, 113 |
263 |
Sunphenon |
- |
- |
- |
- |
2件: 13, 113 |
264 |
Sunphenon egcg |
Epigallocatechin gallate |
- |
- |
- |
3件: 13, 17, 113 |
265 |
Sustanon (testosterone) |
Testosterone |
D00075, D00957, D00958, D00959, D06085, D06087 |
1件: AR |
3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
1件: 113 |
266 |
Tacrolimus |
Tacrolimus |
D00107, D08556 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
29件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
267 |
Tadalafil |
Tadalafil |
D02008 |
1件: PDE5A |
3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
6件: 6, 51, 75, 84, 86, 113 |
268 |
Tadalafil 20 mg |
Tadalafil |
D02008 |
1件: PDE5A |
3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
1件: 113 |
269 |
Tadalafil and sildenafil |
Sildenafil |
D02229, D08514 |
1件: PDE5A |
3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
1件: 113 |
270 |
Tamox |
- |
- |
- |
- |
1件: 113 |
271 |
Tamoxifen |
Tamoxifen |
D00966, D08559 |
2件: ESR1, ESR2 |
9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
4件: 2, 86, 113, 227 |
272 |
Tamoxifen citrate |
Tamoxifen |
D00966, D08559 |
2件: ESR1, ESR2 |
9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
1件: 113 |
273 |
Tas-205 |
- |
- |
- |
- |
1件: 113 |
274 |
Tehalose 30gr |
- |
- |
- |
- |
1件: 113 |
275 |
Temerit |
- |
- |
- |
- |
1件: 113 |
276 |
Testosterone |
Testosterone |
D00075, D00957, D00958, D00959, D06085, D06087 |
1件: AR |
3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
7件: 1, 2, 3, 13, 78, 113, 265 |
277 |
Testosterone enanthate |
Testosterone enanthate |
D00958 |
1件: AR |
3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
1件: 113 |
278 |
Tetracosactide |
Tetracosactide |
D00284 |
1件: MC2R |
5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
4件: 83, 113, 145, 222 |
279 |
Tetracosactide hexaacetate |
Tetracosactide |
D00284 |
1件: MC2R |
5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
1件: 113 |
280 |
Tideglusib |
Tideglusib |
- |
- |
- |
2件: 5, 113 |
281 |
Tranilast |
Tranilast |
D02027 |
- |
- |
4件: 46, 84, 106, 113 |
282 |
Translarna |
Ataluren |
D09323 |
- |
- |
1件: 113 |
283 |
Translarna 1000 mg granules for oral suspension |
Ataluren |
D09323 |
- |
- |
1件: 113 |
284 |
Translarna 125 mg granules for oral suspension |
Ataluren |
D09323 |
- |
- |
1件: 113 |
285 |
Translarna 250 mg granules for oral suspension |
Ataluren |
D09323 |
- |
- |
1件: 113 |
286 |
Treatment phase group 4 |
- |
- |
- |
- |
1件: 113 |
287 |
Triatec |
- |
- |
- |
- |
1件: 113 |
288 |
Umbilical cord based allogenic mesenchymal stem cell |
- |
- |
- |
- |
1件: 113 |
289 |
Umbilical cord mesenchymal stem cell |
- |
- |
- |
- |
1件: 113 |
290 |
Umbilical cord mesenchymal stem cells |
- |
- |
- |
- |
5件: 13, 46, 57, 97, 113 |
291 |
Vamarolone |
- |
- |
- |
- |
1件: 113 |
292 |
Vamorolone |
Vamorolone |
D11000 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
1件: 113 |
293 |
Vamorolone 0.25 mg/day/day |
Vamorolone |
D11000 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
1件: 113 |
294 |
Vamorolone 0.25 mg/kg/day |
Vamorolone |
D11000 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
1件: 113 |
295 |
Vamorolone 0.75 mg/day/day |
Vamorolone |
D11000 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
1件: 113 |
296 |
Vamorolone 0.75 mg/kg/day |
Vamorolone |
D11000 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
1件: 113 |
297 |
Vamorolone 2.0 mg/day/day |
Vamorolone |
D11000 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
1件: 113 |
298 |
Vamorolone 2.0 mg/kg/day |
Vamorolone |
D11000 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
1件: 113 |
299 |
Vamorolone 6.0 mg/day/day |
Vamorolone |
D11000 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
1件: 113 |
300 |
Vamorolone 6.0 mg/kg/day |
Vamorolone |
D11000 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
1件: 113 |
301 |
Vbp15 |
- |
- |
- |
- |
1件: 113 |
302 |
Viltolarsen |
Viltolarsen |
D11528 |
1件: DMD |
4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis |
1件: 113 |
303 |
Vit c vit e zn se |
- |
- |
- |
- |
1件: 113 |
304 |
Wve-210201 |
- |
- |
- |
- |
1件: 113 |
305 |
Wve-210201 (suvodirsen) |
- |
- |
- |
- |
1件: 113 |
306 |
Xeomin |
Botulinum toxin type a |
D00783 |
1件: SNAP25 |
2件: Insulin secretion, Synaptic vesicle cycle |
7件: 5, 6, 7, 13, 15, 17, 113 |